Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
1 Authorization in Canada under the NOC/c guidance was granted based on the acceptable safety profile, high quality and promising efficacy of Wegovy (semaglutide injection) observed in Part 1 of the phase 3 ESSENCE trial
Among non-users, injection aversion remains a meaningful barrier to uptake
It does mean the risk is clinically important enough that it should not be brushed aside
ideally, take unused medication to a drug take-back program or return it to a pharmacy that offers medication disposal services
The study was approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board
US$ 28.43
US$ 24.37
US$ 29.59
US$ 20.38
